Ethris GmbH
Records under this name other than the patents Ethris GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 20 patents it holds.
Showing 1 to 8 of 8 · Back to Ethris GmbH
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,245,229 | Pulmonary Delivery of Mrna to Non-Lung Target Cells Formerly held In force · High confidence | In force | High confidence | |
| US 9,181,321 | CFTR Mrna Compositions and Related Methods and Uses Formerly held In force · High confidence | In force | High confidence | |
| US 9,713,626 | CFTR Mrna Compositions and Related Methods and Uses Formerly held In force · High confidence | In force | High confidence | |
| US 10,420,791 | CFTR Mrna Compositions and Related Methods and Uses Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,510,937 | CFTR Mrna Compositions and Related Methods and Uses Formerly held In force · High confidence | In force | High confidence | |
| US 8,871,230 | Conjugate with Target-Finding Ligand and Use Thereof Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 10,080,804 | Conjugate with Target-Finding Ligand and Use Thereof Lapsed on the fee record Ended Sep 25, 2026 · Medium confidence | Lapsed on the fee record | Ended Sep 25, 2026 | Medium confidence |
| US 8,567,410 | Magnet-field controlled active substance transfer for aerosol therapy Lapsed on the fee record Ended Oct 29, 2025 · From the USPTO record | Lapsed on the fee record | Ended Oct 29, 2025 | From the USPTO record |